ANDA reviewers are practicing meeting deadlines in preparation for imposing formal goal dates on submissions arriving after Oct. 1, likely their biggest challenge in 2014.
It is the next major step in a multi-year trek that has seen FDA negotiate and begin implementation of a user fee program, receive and then abruptly lose a new...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?